Also from this source

You just read:

Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer

News provided by

Jennerex, Inc.

Dec 16, 2010, 02:00 EST